Table 2. Changes in CD4 and Log10 HIV-1 RNA by Treatment.
Treatment | ||||||
Total | Placebo | 2 mg | 4 mg | 8 mg | 16 mg | |
CD4 (cells/:L) | ||||||
N | 186 | 32 | 37 | 38 | 36 | 43 |
Median | −1.5 | −3.5 | −1 | 10.5 | −36.5 | 6 |
Q1, Q3 | −65, 39 | −23, 31 | −69, 41 | −56, 40 | −101, 10.5 | −56, 65 |
p1 | 0.25 | 0.70 | 0.40 | 0.99 | 0.03 | 0.76 |
p2 | 0.68 | 0.70 | 0.07 | 0.55 | ||
Log10 HIV-1 RNA (copies/mL) | ||||||
N | 166 | 30 | 36 | 35 | 32 | 33 |
Median | 0.00 | −0.02 | −0.06 | 0.00 | −0.06 | 0.00 |
Q1, Q3 | −0.27, 0.14 | −0.25, 0.19 | −0.34, 0.09 | −0.10, 0.35 | −0.47, 0.04 | −0.18, 0.05 |
P1 | 0.08 | 0.67 | 0.07 | 0.14 | 0.04 | 0.22 |
P2 | 0.46 | 0.18 | 0.25 | 0.89 |
Signed-rank test for within-arm changes
Wilcoxon rank sum test vs. placebo